US Patent 7285540 Medicament comprising HGF gene
Patent 7285540 was granted and assigned to AnGes MG, Inc. on October, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Ryuichi Morishita0
Takahiro Ochi0
Tetsuya Tomita0
Toshikazu Nakamura0
Toshio Ogihara0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+268 characters)
Article
Patent abstract
The present invention relates to a medicament comprising a HGF gene. The medicament of the present invention may be topically applied to the target organs so that the effects can be selectively exhibited, resulting in minimizing the side effects of HGF.
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07285540 Medicament comprising HGF gene US Patent 7285540 Medicament comprising HGF gene
Infobox
Patent Number
072855400
Patent Number
72855400
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 4 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072855400
Date of Patent
October 23, 2007
0Patent Application Number
106152920
Date Filed
July 9, 2003
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07285540 Medicament comprising HGF gene
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07285540
Date of patent
October 23, 2007
Patent application number
10615292
Date Filed
July 9, 2003
Patent primary examiner
Find more entities like US Patent 7285540 Medicament comprising HGF gene
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
